MedTrace Logo

A Study to Evaluate the Safety of Electronic Vapor Products for 2 Years

NCT02143310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 209

Last updated 2019-07-01

Study results available
· View outcomes & findings →

Summary

Electronic Vapour Products (EVPs) is a relatively new class of consumer products that are otherwise known as electronic cigarettes devices/systems. These may look like conventional cigarettes but do not contain tobacco.

The 'vapour' produced by such devices typically consists of humectants (propylene glycol or glycerol), nicotine, water, and flavours.

This trial is to evaluate the safety and tolerability of an EVP over two years.

Conditions

  • Healthy Volunteers

Interventions

DEVICE

EVP

Sponsors & Collaborators

  • Fontem Ventures BV

    lead INDUSTRY

Principal Investigators

  • Jim Bush, MD · Covance Clinical Research Unit

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-12-29
Completion
2016-12-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02143310 on ClinicalTrials.gov